Vanta Bioscience Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

6.31

6.31

6.31

6.31

6.31

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

13.43

17.68

17.60

17.13

15.93

Loan funds

Secured loans

25.76

20.77

13.30

12.31

12.17

Unsecured loans

-

-

-

-

-

Total

45.50

44.76

37.21

35.75

34.41

Uses of funds

Fixed assets

Gross block

43.69

41.16

19.24

18.37

18.02

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

6.29

5.04

3.72

2.47

1.28

Net block

37.40

36.12

15.52

15.89

16.74

Capital work-in-progress

-

-

13.87

4.86

4.86

Investments

3.00

3.00

3.00

3.00

3.95

Net current assets

Current assets, loans & advances

11.24

11.28

13.86

17.83

12.45

Less : current liabilities & provisions

6.14

5.64

9.04

5.83

3.59

Total net current assets

5.10

5.64

4.82

12.00

8.86

Miscellaneous expenses not written

-

-

-

-

-

Total

45.50

44.76

37.21

35.75

34.41

Notes:

Book value of unquoted investments

3.00

3.00

3.00

3.00

3.95

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

63.12

63.12

63.12

63.12

63.12